• Oxford Science Enterprises appointed Dr. Jeff Moore as Senior Partner, Head of Life Sciences.
• Moore was President at MP Healthcare Venture Management, leading early-stage biotech investments from discovery through exit.
• He holds a DPhil from Oxford, an MBA from MIT.
• Moore replaces Katya Smirnyagina, who stepped back from her executive role.
• Smirnyagina will stay involved as an advisor across key portfolio companies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oxford Science Enterprises PLC published the original content used to generate this news brief on September 29, 2026, and is solely responsible for the information contained therein.